Related Experiment Videos
Breast cancer detection with Tc-99m tetrofosmin
P F Rambaldi1, L Mansi, E Procaccini
1Institute of Radiological Sciences, Second University, Naples, Italy.
Clinical Nuclear Medicine
|August 1, 1995
Summary
Technetium-99m tetrofosmin myocardial SPECT imaging revealed unexpected uptake in the left breast. This finding led to the diagnosis of breast carcinoma, potentially representing the first documented case of neoplastic mammary uptake.
Area of Science:
- Nuclear medicine
- Oncology
- Radiopharmaceuticals
Background:
- Myocardial perfusion imaging is commonly performed using Technetium-99m tetrofosmin (Tc-99m tetrofosmin).
- Tc-99m tetrofosmin is a widely used radiotracer for assessing cardiac function.
Observation:
- An unusual finding of intense focal uptake was noted in the left breast during myocardial SPECT imaging.
- This observation prompted further investigation using mammography.
Findings:
- Mammography indicated a suspicion of breast carcinoma.
- Subsequent surgical confirmation validated the presence of breast carcinoma.
- This case may represent the first reported instance of neoplastic mammary uptake of Tc-99m tetrofosmin.
Implications:
- Tc-99m tetrofosmin uptake in the breast warrants further investigation for potential malignancy.
- This finding could impact the interpretation of myocardial SPECT scans in female patients.
- Further research is needed to understand the mechanism and clinical significance of Tc-99m tetrofosmin uptake in breast tissue.